Dashboard
Manage Tickers

HALO HALOZYME THERAPEUTICS, INC.

Nasdaq halozyme.com


$ 65.30 $ 0.00 (0 %)    

Tuesday, 14-Oct-2025 07:00:08 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 594.54 $ 0.00 (0 %)
DIA $ 456.90 $ 0.00 (0 %)
SPY $ 656.59 $ 0.00 (0 %)
TLT $ 90.84 $ 0.00 (0 %)
GLD $ 378.18 $ 0.00 (0 %)
$ 65.33
$ 64.10
$ 64.75 x 100
$ 65.33 x 4
-- - --
$ 42.01 - $ 79.50
1,652,877
na
7.64B
$ 0.92
$ 13.71
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-18-2025 12-31-2024 10-K
4 10-31-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-20-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 02-21-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 02-22-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 02-23-2021 12-31-2020 10-K
20 11-02-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 02-24-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 02-20-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 02-28-2017 12-31-2016 10-K
36 11-07-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-90
HC Wainwright & Co. Maintains Buy on Haloz...
10/02/2025 10:33:51

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the p...

halozyme-to-acquire-elektrofi-in-deal-comprising-of-750m-upfront-payment-and-up-to-three-50m-milestone-payments-contingent-on-three-separate-product-regulatory-approvals-royalty-revenue-contribution-expected-as-early-as-2030
Halozyme To Acquire Elektrofi In Deal Comp...
10/01/2025 11:05:20

benchmark-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-90
Benchmark Maintains Buy on Halozyme Therap...
09/24/2025 12:24:30

Benchmark analyst Robert Wasserman maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the price target from...

forecasting-the-future-7-analyst-projections-for-halozyme-therapeutics
Forecasting The Future: 7 Analyst Projecti...
09/22/2025 12:02:57

hc-wainwright--co-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-85
HC Wainwright & Co. Maintains Buy on Haloz...
09/22/2025 10:36:37

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the p...

what-7-analyst-ratings-have-to-say-about-halozyme-therapeutics
What 7 Analyst Ratings Have To Say About H...
08/18/2025 20:01:43

morgan-stanley-maintains-overweight-on-halozyme-therapeutics-raises-price-target-to-80
Morgan Stanley Maintains Overweight on Hal...
08/18/2025 12:52:31

Morgan Stanley analyst Vikram Purohit maintains Halozyme Therapeutics (NASDAQ:HALO) with a Overweight and raises the price t...

jp-morgan-maintains-neutral-on-halozyme-therapeutics-raises-price-target-to-63
JP Morgan Maintains Neutral on Halozyme Th...
08/07/2025 19:17:29

JP Morgan analyst Jessica Fye maintains Halozyme Therapeutics (NASDAQ:HALO) with a Neutral and raises the price target from ...

what-does-the-market-think-about-halozyme-therapeutics
What Does the Market Think About Halozyme ...
08/07/2025 18:00:45

jmp-securities-maintains-market-outperform-on-halozyme-therapeutics-raises-price-target-to-91
JMP Securities Maintains Market Outperform...
08/06/2025 15:09:07

JMP Securities analyst Jason N. Butler maintains Halozyme Therapeutics (NASDAQ:HALO) with a Market Outperform and raises the...

hc-wainwright--co-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-75
HC Wainwright & Co. Maintains Buy on Haloz...
08/06/2025 12:04:34

HC Wainwright & Co. analyst Mitchell Kapoor maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the pric...

morgan-stanley-upgrades-halozyme-therapeutics-to-overweight-raises-price-target-to-75
Morgan Stanley Upgrades Halozyme Therapeut...
08/06/2025 11:19:44

Morgan Stanley analyst Vikram Purohit upgrades Halozyme Therapeutics (NASDAQ:HALO) from Equal-Weight to Overweight and raise...

correction-halozyme-therapeutics-q2-adj-eps-154-beats-123-estimate-sales-325719m-beat-281588m-estimate
CORRECTION: Halozyme Therapeutics Q2 Adj. ...
08/05/2025 20:03:21

Halozyme Therapeutics (NASDAQ:HALO) reported quarterly earnings of $1.54 per share which beat the analyst consensus estimate of...

halozyme-therapeutics-raises-fy2025-adj-eps-guidance-from-530-570-to-600-640-vs-550-est-raises-fy2025-sales-guidance-from-1200b-1280b-to-1275b-1355b-vs-1252b-est
Halozyme Therapeutics Raises FY2025 Adj EP...
08/05/2025 20:02:20

Halozyme Therapeutics (NASDAQ:HALO) raises FY2025 Adj EPS guidance from $5.30-$5.70 to $6.00-$6.40 vs $5.50 analyst estimate. R...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

earnings-outlook-for-halozyme-therapeutics
Earnings Outlook For Halozyme Therapeutics
08/04/2025 15:04:24

Core News & Articles
'European Commission Approves DARZALEX As ...
07/23/2025 12:42:30

https

1000-invested-in-this-stock-15-years-ago-would-be-worth-this-much-today
$1000 Invested In This Stock 15 Years Ago ...
07/22/2025 20:15:18

jp-morgan-maintains-neutral-on-halozyme-therapeutics-raises-price-target-to-60
JP Morgan Maintains Neutral on Halozyme Th...
07/16/2025 18:03:36

JP Morgan analyst Jessica Fye maintains Halozyme Therapeutics (NASDAQ:HALO) with a Neutral and raises the price target from ...

heres-how-much-you-would-have-made-owning-halozyme-therapeutics-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
07/07/2025 14:30:17

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION